2 October 2025

Dermatology PBAC PBS Pharmaceuticals

‘Unsustainable’: Pfizer pulls out of JAKi PBS application

7 August 2025

Biosimilars PBAC

Biosimilars denosumab and tocilizumab head to PBAC

26 June 2025

Hidradenitis Suppurativa PBAC PBS

Written approval required for bimekizumab injections in HS

7 November 2024

PBAC PBS

PBAC brings more relief to rheum patients

7 November 2024

PBAC Political

PBAC defers 44 submissions due to capacity constraints

29 April 2024

PBAC PBS Pharmaceuticals

Rheum drugs PBAC bonanza

11 April 2024

PBAC TGA

Abatacept shortage strikes again

1 February 2024

PBAC Pharmaceuticals

Free Shingrix for rheum patients gets PBAC nod

19 October 2023

PBAC

PBAC gives nurse practitioner MTX prescribing the nod

21 August 2023

Medications PBAC PBS

Shingrix to be funded from 1 November

22 June 2023

PBAC PBS The Hill

Shingrix funding gap points way forward

21 June 2023

PBAC PBS The Hill

We need faster approval of new drugs

24 April 2023

PBAC Pharmaceuticals Vaccines

Shingrix PBAC boon for immunocompromised

24 April 2023

Lupus Osteoporosis PBAC Plaque psoriasis Psoriatic Athritis

Anifrolumab decision headlines PBAC outcomes

2 February 2023

Biosimilars COVID-19 Paediatric PBAC PBS

Groundhog day for Evusheld’s PBS quest

21 September 2022

PBAC

Deucravacitinib FDA approved for plaque psoriasis